Morgan Stanley lowered Macy's target price from $17.00 to $16.00.Jianfan Bio: The plasma separator was certified by the European Union MDR, and Jianfan Bio announced that Jianfan Blood Purification Company, a wholly-owned subsidiary, recently received a notice from the EU announcement agency that its plasma separator was certified by the European Union MDR in accordance with the EU Medical Devices Regulation 2017/745, and can be sold in EU countries and other countries that recognize the EU CE certification.Japan's semiconductor sector rose collectively, with ADVANTEST up nearly 5%, DISCO up over 2% and Renesas Electronics up over 1%.
Institution: The Swiss National Bank does not need to cut interest rates sharply again. Melanie Debono, a macroeconomic analyst at Pantheon, wrote in a report that the Swiss National Bank does not need to cut borrowing costs sharply again. Earlier, the Swiss National Bank unexpectedly cut interest rates by 50 basis points. Most analysts had expected a more cautious rate cut of 25 basis points. Debono said that there may be further relaxation after this move, but only a little. Pantheon Macroeconomics predicts that the Swiss National Bank will cut interest rates by 25 basis points again in March next year.Yiwangyichuang: Shareholder Zhang Fan plans to reduce his shareholding by no more than 1%. Yiwangyichuang announced that shareholder Zhang Fan, who holds more than 5% of the company's shares, plans to reduce his shareholding by centralized bidding and/or block trading, and the number of shares to be reduced is no more than 2,369,400, accounting for 1.00% of the company's total share capital. The reduction period is from January 6, 2025 to April 4, 2025. The price range of reduction will be determined according to the market price and trading method at the time of reduction. The reason for Zhang Fan's reduction is based on his own capital demand, and the shares come from the shares issued before the initial public offering, the shares transferred due to equity distribution and the shares transferred by agreement.Laimei Pharmaceutical Co., Ltd.: The controlling shareholder intends to transfer 23.43% of the shares by agreement. Laimei Pharmaceutical announced that Zhongheng Group, the controlling shareholder, intends to transfer 247 million shares of the company's unrestricted tradable A shares by public solicitation of the transferee, accounting for 23.43% of the company's total share capital, and the transfer price is not less than 4.42 yuan/share. If the share transfer is completed, the controlling shareholder and actual controller of the company may change.
18 shares were rated by brokers, and Yuhetian's target increased by 54.72%. On December 11th, a total of 18 shares were rated by brokers, and 6 of them announced their target prices. According to the highest target price, Yuhetian, Steady Medical Care and Fulongma ranked in the top, with increases of 54.72%, 19.96% and 17.62% respectively. Judging from the direction of rating adjustment, the ratings of 12 stocks remain unchanged and 6 stocks are rated for the first time. In addition, one stock attracted the attention of many brokers, and Hagrid Communications was ranked in the top number, with two brokers rating it respectively. Judging from the Wind industry to which the rated stocks are bought, the number of rated stocks for technical hardware and equipment, capital goods and materials II is the largest, with 4, 3 and 2 respectively.Polish Prime Minister Tusk told French President Macron that even if Russia and Ukraine cease fire, Polish troops will not enter Ukraine.In the first 11 months of the North Stock Exchange, the issuance scale of new shares decreased by nearly 770% year-on-year, and the new shares rose by over 100% on the first day. Statistics show that from January to November, 2024, there were 20 new shares listed on the North Stock Exchange, and the total amount of funds raised was about 4.175 billion yuan, down by nearly 70% year-on-year. The scale of new shares is generally small, and the number of new shares raised less than 200 million yuan accounts for 65% of the total number of new shares. The share price of 70% new shares rose over 100% on the first day of listing. Among them, the share price of Tongguan Mining Construction rose by 731.41% on the first day of listing, and the share prices of Shengye Electric, Keli and Wanyuantong rose by over 300% on the first day. In terms of underwriters, in the first November of 2024, the number of projects underwritten by CITIC Jiantou Securities was the highest, with a total project scale of about 699 million yuan, followed by First Venture Securities and Minsheng Securities. (Xinhua Finance)
Strategy guide
12-14
Strategy guide
Strategy guide
12-14